Literature DB >> 19302253

Beta1-integrins shedding in a guinea-pig model of chronic asthma with remodelled airways.

B Bazán-Perkins1, E Sánchez-Guerrero, M H Vargas, E Martínez-Cordero, P Ramos-Ramírez, M Alvarez-Santos, G Hiriart, M Gaxiola, R Hernández-Pando.   

Abstract

BACKGROUND: A hallmark of airway remodelling in asthma is subepithelial fibrosis, but its relation with airway dysfunction is still controversial.
OBJECTIVE: To describe airway functional abnormalities and subepithelial remodelling induced by repetitive antigenic challenges.
METHODS: Nine inhaled antigenic challenges were applied every 10 days to guinea-pigs sensitized to ovalbumin (OVA). Antigen-induced airway hyperresponsiveness (AI-AHR) to histamine and its immunohistopathological relationship was evaluated at the first, third and ninth OVA challenges.
RESULTS: From the first challenge on, OVA induced acute transient bronchoobstruction followed by development of AI-AHR. A progressive rise in baseline Penh (a bronchoobstruction index) and granulocyte airway infiltration was also observed. After the ninth OVA challenge, the amount of extracellular matrix in the subepithelial region (SER) of bronchi and bronchioles was increased. Immunohistochemistry analysis showed that this SER fibrosis was associated to beta1-integrin subunit overexpression, even in acellular areas. Immunoelectronmicroscopy corroborated the location of beta1-integrin in extracellular matrix, essentially in types l and II collagen fibres. Presence of alpha1- and alpha2-integrin subunits in these areas was also corroborated. AI-AHR was correlated with degree of SER increment, cell infiltration, and beta1-integrin expression.
CONCLUSION: Our data suggested that beta1-integrin shedding produced by repetitive allergen challenges in guinea-pigs was associated with collagen deposition in SER of bronchi and bronchioles, along with inflammatory cells infiltration and AI-AHR development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302253     DOI: 10.1111/j.1365-2222.2009.03208.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma.

Authors:  Paola Moreno-Alvarez; Edgar Sánchez-Guerrero; Erasmo Martínez-Cordero; Rogelio Hernández-Pando; María G Campos; Lucely Cetina; Blanca Bazán-Perkins
Journal:  Lung       Date:  2009-12-09       Impact factor: 2.584

2.  Integrin and GPCR Crosstalk in the Regulation of ASM Contraction Signaling in Asthma.

Authors:  Chun Ming Teoh; John Kit Chung Tam; Thai Tran
Journal:  J Allergy (Cairo)       Date:  2012-09-29

3.  Antigen-induced airway hyperresponsiveness and obstruction is related to caveolin-1 expression in airway smooth muscle in a guinea pig asthma model.

Authors:  Mayra Álvarez-Santos; Patricia Ramos-Ramírez; Fernando Gutiérrez-Aguilar; Sandra Sánchez-Hernández; Ricardo Lascurain; Raúl Olmos-Zuñiga; Rogelio Jasso-Victoria; Norma A Bobadilla; Blanca Bazan-Perkins
Journal:  Clin Transl Allergy       Date:  2015-03-26       Impact factor: 5.871

4.  Interstitial collagen turnover during airway remodeling in acute and chronic experimental asthma.

Authors:  Georgina González-Avila; Blanca Bazan-Perkins; Cuauhtémoc Sandoval; Bettina Sommer; Sebastian Vadillo-Gonzalez; Carlos Ramos; Arnoldo Aquino-Galvez
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

5.  Silencing of β1 integrin regulates airway remodeling by regulating the transcription of SOCE‑associated genes in asthmatic mice.

Authors:  Chen Qiu; Wenwen Liu; Fei Shi; Mengjie Fen; Lili Ren; Hui Qi
Journal:  Mol Med Rep       Date:  2017-06-27       Impact factor: 2.952

6.  Role of airway smooth muscle cell phenotypes in airway tone and obstruction in guinea pig asthma model.

Authors:  Mayra D Álvarez-Santos; Marisol Álvarez-González; Elizabeth Eslava-De-Jesus; Angel González-López; Ivonne Pacheco-Alba; Yazmín Pérez-Del-Valle; Rodrigo Rojas-Madrid; Blanca Bazán-Perkins
Journal:  Allergy Asthma Clin Immunol       Date:  2022-01-11       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.